Data / Form D filings / Virica Biotech Inc.
Virica Biotech Inc.: Form D filings
Virica Biotech Inc., a biotechnology company in Ottawa, Ontario, Canada, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on May 13, 2024, reports $60,000 sold of an offering with no set size to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7 BAYVIEW STATION ROAD, Ottawa, Ontario, Canada, K1Y 2
- Phone
- (613) 737-8899
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1892496
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2024 | New notice | Indefinite | $60,000 | 2 | Apr 29, 2024 | sec.gov | |
| Jan 26, 2024 | New notice | $2,999,999 | $2,999,999 | 2 | Jan 22, 2024 | sec.gov | |
| Jun 16, 2022 | New notice | $499,999 | $499,999 | 1 | Apr 25, 2022 | sec.gov | |
| Nov 19, 2021 | New notice | $3,499,999 | $3,499,999 | 1 | Sep 27, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniella Kranjac | Director | |
| Susan Dexter | Director | |
| Jean-Simon Dr. Diallo | Director, Executive Officer | |
| Ella Korets-Smith | Executive Officer | |
| Ken Newport | Director, Executive Officer |
Every Form D from the week of May 13, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Virica Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.